Last updated: February 20, 2026
Zaroxolyn (methazolamide) is a carbonic anhydrase enzyme inhibitor used primarily for glaucoma, edema, and congenital hyperbilirubinemia. Sourcing quality APIs is critical for consistent drug manufacturing. This analysis covers the primary bulk API sources for methazolamide, including geographic distribution, manufacturers, and supply chain considerations.
Major API Manufacturers and Market Distribution
Leading Manufacturers
| Manufacturer |
Location |
API Production Capacity |
Notable Certifications |
Supply Chain Status |
| Hetero Drugs Ltd. |
India |
10+ metric tons/year |
WHO-GMP, ISO 9001 |
Active supplier, global exports |
| Sino Biopharmaceutical Ltd. |
China |
5+ metric tons/year |
GMP, ISO 9001 |
A significant supplier for Asia, exports to Europe and North America |
| Mundipharma International |
Netherlands (European base) |
Limited, specialized production |
GMP |
Currently supplies through licensed partnerships |
| Indoco Remedies |
India |
Small scale |
WHO-GMP |
Used in regional markets |
Other Notable Sources
- Az Chemistry Inc., USA: Niche supplier with custom manufacturing capacity.
- Aurobindo Pharma, India: Has produced methazolamide APIs for internal use and external licensing agreements.
- Teva Pharmaceutical Industries, Israel: Produced APIs for generic formulations, including small quantities.
Geographic Distribution
- India: Dominant source of bulk API, with multiple facilities adhering to international GMP standards.
- China: Supplies sizable quantities, primarily to the Asian markets and some exports to North America and Europe.
- Europe: Limited producers, usually linked to subsidiaries or subsidiaries of larger manufacturers.
Supply Chain Dynamics and Considerations
- Regulatory Standards: Most suppliers comply with WHO-GMP and/or US FDA standards; certifications ensure manufacturing quality.
- Capacity Constraints: API production capacity varies; Indian manufacturers generally have larger capacities.
- Pricing Trends: API prices fluctuate based on capacity utilization and raw material costs. Indian APIs tend to be more cost-effective.
- Supply Security: Geopolitical tensions and trade policies influence API availability, especially from China.
Quality and Certification Aspects
- Strict adherence to GMP ensures API purity (>99%) and consistent batch-to-batch quality.
- Certificates of Analysis (COA) and stability data are standard documentation provided.
- Some suppliers hold US FDA approvals; others meet EU regulations or WHO prequalification standards.
Market Entry and Licensing
- Several Indian manufacturers hold licensing agreements with Western pharma companies.
- Chinese suppliers often export under their own brand or OEM arrangements.
- Validation protocols are necessary for regulatory approval in target markets.
Summary Table of API Sources
| Supplier |
Location |
Capacity (Approximate) |
Certification |
Lead Time (Weeks) |
| Hetero Drugs Ltd. |
India |
10+ metric tons/year |
WHO-GMP, ISO 9001 |
4–6 |
| Sino Biopharmaceutical Ltd. |
China |
5+ metric tons/year |
GMP |
6–8 |
| Mundipharma International |
Netherlands |
Small-scale |
GMP |
8–10 |
| Aurobindo Pharma |
India |
Moderate |
GMP |
4–6 |
Key Considerations for Procurement
- Verify supplier certifications to meet regional regulatory requirements.
- Confirm capacity and lead times to avoid supply disruptions.
- Prefer suppliers with proven track records of consistent API quality.
Key Takeaways
- India's Hetero and Aurobindo are primary API sources for methazolamide.
- China supplies significant API quantities, mainly to Asia and export markets.
- European supply is limited but available through specialized manufacturers.
- Quality standards such as GMP, ISO, and US FDA approvals are critical for supplier selection.
- Supply chain risks include capacity constraints and geopolitical factors.
FAQs
1. What are the main regions producing ZAROXOLYN API?
India and China are the primary regions, with India leading in capacity and quality assurance.
2. Which certifications ensure API quality for global markets?
GMP certification, ISO 9001 accreditation, and US FDA approval are standard benchmarks.
3. How does supply chain security influence API sourcing?
Dependence on single-region suppliers increases risk; diversifying sources mitigates disruptions.
4. Are there any exclusive API manufacturers for ZAROXOLYN?
No; several manufacturers produce methazolamide, providing competition and supply flexibility.
5. What considerations should biopharmaceutical companies prioritize when sourcing API?
Quality certification, capacity, lead times, regulatory compliance, and historical supply reliability.
References
- U.S. Food and Drug Administration. (2021). Guidance for Industry: Quality Systems Approach to Pharmaceutical Quality.
- World Health Organization. (2020). Prequalification of Medicines Programme.
- Indian Pharmaceutical Association. (2022). Report on API Manufacturing Capabilities.
- China Pharmaceutical Industry Association. (2021). API Market Overview.
- European Medicines Agency. (2022). Certification and Regulatory Standards for APIs.
